CC LP

7K posts

CC LP banner
CC LP

CC LP

@CCapLP

Generalist. Tweets are never investment advice nor represent views of anyone else, except CC LP

Katılım Mart 2011
894 Takip Edilen1K Takipçiler
CC LP retweetledi
Jack Posobiec
Jack Posobiec@JackPosobiec·
NEW: From what I’m hearing from both the US and Gulf sides, this deal is exactly what Trump has been asking for out of any deal. Main portion includes no nuclear weapon and the Strait of Hormuz will be opened during a 60-day negotiating period
English
828
948
6.7K
1.5M
CC LP retweetledi
First Squawk
First Squawk@FirstSquawk·
TRUMP PREDICTS IRAN CONFLICT WILL SOON COME TO AN END.
English
37
32
522
49K
CC LP
CC LP@CCapLP·
@OilandGibbs What % YoY supply growth do you anticipate? Pre spring shutdowns we were at +2.5-3.0%
English
0
0
0
129
Brett Gibbs
Brett Gibbs@OilandGibbs·
Ethanol prices are stuck. Runaway US supply has commenced as of 2026 thanks to the removal of indirect land use change penalties in 45Z, granting most producers 10 cents a gallon of credit. Despite record low gasoline parity (under 55%), crush margins are still above 5-year averages thanks to coproducts. This is even before including 45Z. Part of the weakness is because Brazil is subsidizing gasoline prices, with prices to distributors sub-$2/gal. Brazil gasoline eventually will have to come up, yet an 18% duty curbs access as the arb into the EU (not-UK) is still closed. With E15 locked up in Congress (and gradual rollout anyway), the US is going to need to find a home for its tax-credit hungry supply. Mexico and Canada are the easiest. Waterborne expansion may require weaker wholesale prices to reach non-Gulf ports and absorb heavy global duties.
English
3
4
23
4K
CC LP retweetledi
Barchart
Barchart@Barchart·
Hedge Funds have increased their short exposure to the highest level in AT LEAST the last decade 🚨🚨
Barchart tweet media
English
107
263
1.5K
170.6K
CC LP
CC LP@CCapLP·
@TheNarrenschiff @lebron_ex What if the 45Z cash flows have geological or injection risk that the market is accounting for? Have you look at WY injection data? $GPRE
English
1
0
0
74
Paul Narrenschiff
Paul Narrenschiff@TheNarrenschiff·
@lebron_ex And by that I mean obviously it's too cheap on the 45Z cash flows, but that has a 7-year window if no extension (which I wouldn't bet on). But even the 45Q plus some of the HighPro is worth more, and the sugar tech is really, really interesting even though they did a shit job.
English
2
0
1
78
Heisenberg
Heisenberg@Mr_Derivatives·
$TSLA $425 overnight..
English
40
11
466
52.8K
CC LP retweetledi
Deep Inference
Deep Inference@DeepInference·
Simple Bottom Line SATS fair value at the S-1 anchor of $1.75T: $194 per share. That is 41% above the current $137.79 price. This is the most conservative scenario where SpaceX prices exactly where the S-1 says. SATS fair value if the SPCX perp is right at $2.5T: $259 per share. That is 88% above current price. SATS fair value if SPCX opens above $3T via the CBRS pattern: $302 per share. That is 119% above current price. What SATS is actually priced at today: A SpaceX worth $1.0T to $1.4T, which is below every external reference point including the S-1, the Scottish Mortgage mark, the SPCX perp, and the recent xAI merger mark. The trade is not "is SATS cheap." The math says it obviously is. The trade is "why has the gap not closed." Best answers are deal-close risk, tax uncertainty, and Ergen overhang. Each of those is real but small relative to a 40% to 100% upside gap. The dislocation is SATS, not SPCX. SPCX on tradeXYZ is doing what perps do, sitting at roughly a 50% premium to where the institutional book will price. That is essentially identical to the CBRS perp behavior. SATS is the asymmetric trade because it gives you direct ownership at a discount to even the most conservative SpaceX valuation, while SPCX is a leveraged bet on the IPO mechanics playing out a specific way.
English
3
6
31
16.1K
CC LP
CC LP@CCapLP·
@elonmusk @AnthropicAI @SpaceX $SPCX / $SATS -- SpaceX disclosed a massive compute agreement with AI rival Anthropic. The contract stipulates a $1.25 billion monthly compute agreement running through May 2029
English
0
0
1
35
Elon Musk
Elon Musk@elonmusk·
As the recently expanded partnership with @AnthropicAI demonstrates, @SpaceX is offering AI compute as a service at significant scale. We are in discussions with other companies to do the same. Over time, especially with orbital data centers, we expect to serve AI at extremely high scale.
English
4K
7.3K
72.8K
14.5M
CC LP
CC LP@CCapLP·
@Slack_Capital @eXoZymes @MDBCapital 1. $EXOZ has been in market since April 10th. No concerns? How do you know about the close date? 2. ATM Facility? Stock trades 2-5k shares per day, at 15% of the market, you could issue about $5,000 of stock per day. Are you kidding me?
English
1
0
0
108
James - Slack Capital
James - Slack Capital@Slack_Capital·
The company is currently raising $10-15 million via @MDBCapital. This should close within the next two weeks so no concerns there. Given that their annual burn rate is ~ $10m, the funding will provide them with 12 months of clearance. Expecting to receive additional grants along with the first revenues from their NCT OTC launch. Plenty of catalysts coming up in Q3 and with their ATM facility, they can tap into public markets are well
English
1
0
1
53
James - Slack Capital
James - Slack Capital@Slack_Capital·
The next major catalyst for $EXOZ is its NCT human-use studies Positive indications won't just validate a single product, they will reveal the true extent of @eXoZymes near-term investment opportunity Preclinical NCT mouse models have already shown impressive effects on liver fat, mitochondrial function and metabolic health, including a 30% reduction in body weight With @eXoZymes' demonstrated ability to produce <99% pharmaceutical grade NCT, translation of prior mouse studies into humans would provide decisive validation for: → NCT as a world-class compound entering a 100B+ metabolic health and longevity wellness market → NCTx, the company's spin‑out entity, which holds the commercial rights and is driving near-term OTC revenues → eXoZymes' NCT Pharma Analog program, which is developing more potent, patent-protected drug candidates for some of the world's most valuable disease markets With human use studies currently underway, the market could receive its answers as soon as Q3 2026 If the human data confirms what preclinical work has already suggested, investors won't just be looking at another "milestone"... they'll be looking at a major re‑rating in $EXOZ shares
James - Slack Capital tweet media
English
1
2
10
1.1K
Dan
Dan@dan_tmt·
That's not how I read it at all. They said that Echostar did not meet their build deadlines according to the FCC so the FCC was going to take away the spectrum. That is not a force majeure. That is Echostar screwing up. They then sold the spectrum so that the spectrum wasn't taken away.
English
1
0
1
295
CC LP
CC LP@CCapLP·
$SPCX IPO S-1 is filed! 🚀 $SATS “You want to wake up in the morning and think the future is going to be great—and that’s what being a space-faring civilization is all about. It’s about believing in the future and thinking that the future will be better than the past. And I can’t think of anything more exciting than going out there and being among the stars.”—Elon Musk
English
0
0
5
454
CC LP
CC LP@CCapLP·
Is $FRVO a short?
English
0
0
0
243
DPrad
DPrad@day_to_Mars·
How much cash should I keep on hand to invest in SpaceX Anthropic and OpenAI? Let’s say I am a billionaire.
English
1
0
1
155
CC LP retweetledi
CC LP
CC LP@CCapLP·
@darkstarsats @dan_tmt @WaltLightShed $SATS (via Gemini) The DOJ ruling significantly bolsters EchoStar's attempt to claim a tax deferral under IRC Section 1033, though the success of the maneuver is not entirely assured
English
0
1
3
1.6K
CC LP retweetledi
CC LP
CC LP@CCapLP·
$SATS - (via Gemini) "The ruling is highly helpful for EchoStar in its attempt to shed these obligations, although it has triggered significant legal battles with tower providers. By officially terminating the mandate that EchoStar build and operate a nationwide 5G network, the DOJ ruling provides the company with the regulatory justification it needs to abandon its physical cell tower infrastructure. $AMT $SBAC $CCI
English
2
1
4
712